Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
146.46
-0.36 (-0.25%)
Streaming Delayed Price
Updated: 3:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
April 22, 2024
From
Johnson & Johnson
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
April 22, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
MarketBeat Week in Review – 4/15 - 4/19
April 20, 2024
The markets continued to move lower ahead of a big earnings week as analysts adjust valuations on the outlook for interest rates and geopolitical concerns
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Bev Jennings selected as VIP Speaker at Global Women Thrive Summit 2024
March 16, 2024
The presentation is virtual and live in-person as part of a collaboration with the WBENC Amplify Conference in Denver, COJACKSONVILLE, Fla. & DENVER - March 16, 2024 - PRLog -- Bev Jennings, a VIP...
Via
PRLog
Topics
Supply Chain
Exposures
Supply Chain
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
April 17, 2024
Johnson & Johnson's Q1 2024 earnings offer a mixed picture of resilience amidst economic headwinds and provide insight into the broader medtech sector's health.
Via
MarketBeat
Topics
Economy
Exposures
COVID-19
Supply Chain
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson is as Cheap as it’s Going to Get
April 16, 2024
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely.
Via
MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
April 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Star Surgical Shines as U.S. Outlook Improves for 2024
April 16, 2024
STAAR Surgical is increasing its outlook and guidance as demand for its signature IOL procedure increases with an aging population
Via
MarketBeat
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
April 15, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
MarketBeat Week in Review – 4/8 - 4/12
April 13, 2024
The latest inflation readings moved stocks lower as investors reconsidered what higher-for-longer interest rates mean for corporate earnings and stock valuation
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
April 08, 2024
From
Johnson & Johnson
Via
Business Wire
Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
April 08, 2024
Johnson & Johnson's proposed acquisition of Shockwave Medical may be the jolt that JNJ stock needs to break out of a year-long downtrend
Via
MarketBeat
Johnson & Johnson to Acquire Shockwave Medical
April 05, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
April 04, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the BofA Securities Health Care Conference
April 02, 2024
From
Johnson & Johnson
Via
Business Wire
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The Next Great Biotech Boom Has Arrived
March 19, 2024
EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 11, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Completes Acquisition of Ambrx
March 07, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
February 14, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
February 12, 2024
From
Johnson & Johnson
Via
Business Wire
Verizon, Walgreens, 3M: 3 high-yield Dow stocks to buy now?
February 05, 2024
Dow's high-yielding trio, Verizon, Walgreens, and 3M face challenges, which are reflected in their stock-price declines.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference
February 02, 2024
From
Johnson & Johnson
Via
Business Wire
4 med tech stocks with improving prognosis for 2024
January 31, 2024
MedTech stocks have had plenty of reason to rally over the last year but haven't. That is about to change with growth accelerating in 2024 and 2025.
Via
MarketBeat
Exposures
COVID-19
Abbott Laboratories on track for new highs in 2024
January 25, 2024
Abbott Laboratories is a solid dividend play whose underlying business is returning to growth after years of COVID-19 impact.
Via
MarketBeat
Exposures
COVID-19
Intuitive Surgical’s post-earnings dip is a healthy time to buy
January 25, 2024
Intuitive Surgical had a solid quarter, but strength was expected, and the stock sold off; a healthy correction is good, but will investors buy the dip?
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Johnson & Johnson's stock price is at a critical turning point
January 23, 2024
Johnson & Johnson's dividend is safe for 2024 and may include another increase for this Dividend King. Results suggest another solid quarter for medtech.
Via
MarketBeat
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
3 personal care stocks that smell like good earnings plays
January 23, 2024
Management remarks about how they plan to use technology to drive growth could matter just as much as near-term financials for these personal care companies.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.